PMC:7317273 / 21165-21295
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T141 | 110-114 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T46 | 110-114 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T247 | 110-114 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T248 | 110-114 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T85 | 50-60 | Chemical | denotes | paclitaxel | http://purl.obolibrary.org/obo/CHEBI_45863 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 328 | 50-60 | Chemical | denotes | paclitaxel | MESH:D017239 |
| 337 | 110-124 | Disease | denotes | lung anomalies | MESH:D008171 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T327 | 0-130 | Sentence | denotes | Further, employing pharmacological agents such as paclitaxel to prime MSCs could also be helpful in improving lung anomalies [37]. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32592163-28153512-140679198 | 126-128 | 28153512 | denotes | 37 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T363 | 19-41 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological agents |
| T364 | 50-60 | CHEBI:45863;CHEBI:45863 | denotes | paclitaxel |
| T365 | 70-74 | DG_47 | denotes | MSCs |
| T366 | 110-114 | UBERON:0002048 | denotes | lung |